Compare PMTS & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PMTS | ORMP |
|---|---|---|
| Founded | 2007 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.1M | 165.3M |
| IPO Year | 2015 | 2010 |
| Metric | PMTS | ORMP |
|---|---|---|
| Price | $18.87 | $3.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $27.67 | N/A |
| AVG Volume (30 Days) | 43.6K | ★ 194.8K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | 0.17 | ★ 0.91 |
| Revenue | ★ $312,189,000.00 | $2,000,000.00 |
| Revenue This Year | $9.95 | N/A |
| Revenue Next Year | $10.02 | N/A |
| P/E Ratio | $108.94 | ★ $4.07 |
| Revenue Growth | 12.27 | ★ 49.25 |
| 52 Week Low | $10.81 | $1.98 |
| 52 Week High | $25.37 | $5.01 |
| Indicator | PMTS | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 63.69 | 47.04 |
| Support Level | $13.10 | $3.21 |
| Resistance Level | $19.52 | $3.96 |
| Average True Range (ATR) | 1.02 | 0.23 |
| MACD | 0.21 | -0.04 |
| Stochastic Oscillator | 97.94 | 32.35 |
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit segment, which principally produce secure debit and credit cards and provide card services for U.S. card-issuing financial institutions, including personalization, instant issuance and other payment solutions such as digital push provisioning for mobile wallets; Prepaid Debit, which provides secure packaging solutions, Prepaid Debit Cards, and other integrated prepaid card services to prepaid program managers in the U.S.; and other: principally corporate expenses. The firm generates key revenue from Debit and Credit segment.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.